Key Takeaways

Dr. Richard Pazdur will lead the the U.S. Food and Drug Administration main drug division

The division lost about 1,000 staff this year amid turnover and morale concerns

Pazdur, a 26-year veteran of the agency, is known for speeding up cancer drug approvals

THURSDAY, Nov. 13, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has appointed one of its most respected cancer drug regulators to lead the agency’s main division for approving new drugs.

The appointment of Dr. Richard Pazdur comes after a turbulent year with hundreds of staff departures within the agency.

Pazdur, who has been with FDA for 26 years, is known for helping speed the approval of lifesaving cancer drugs.

His new role places him at the helm of the Center for Drug Evaluation and Res

See Full Page